^
    BIOMARKER:

    MET mutation

    i
    Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase




    Show legend

    Include preclinical:
    Renal Cell Carcinoma
    Non Small Cell Lung Cancer
    Gastric Cancer
    savolitinib
    crizotinib
    MGCD265
    sunitinib
    everolimus
    durvalumab + savolitinib
    GSK1363089
    TPX-0022
    cabozantinib capsule
    MTI-31
    Immunotherapy
    c-MET inhibitor